Recent investigations have elucidated the role of IL-13Rα2 as a tumor-associated antigen that mediates aberrant STAT3 signaling, driving increased expression of anti-apoptotic genes and, ultimately, promoting tumor progression by blocking cell death and mediating survival [17,59,60]. Here, IL13RA2 is linked to neoplasm.